Jason Bosiacki

Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking human LAIR-collagen interaction

M. Karsdal, S. Langermann, S. Willems, 2021, eLife.

Cancer immunotherapy by NC410, a LAIR-2 Fc protein blocking LAIR-collagen interaction

S. Langermann, S. Willems, D. Flies, 2020, bioRxiv.

The FLRT3-UNC5B checkpoint pathway inhibits T cell–based cancer immunotherapies

D. Langenau, D. Flies, Qiqi Yang, 2024, Science advances.